查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2087678

血管支架市場：全球市場按產品類型、材質、輸送系統、應用和最終用戶分類的預測——2026-2032年

Vascular Stent Market by Product Type, Material, Delivery System, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血管支架市場將成長至 167.3 億美元，複合年成長率為 5.51%。

主要市場統計數據
基準年 2025 114.9億美元
預計年份：2026年 120.9億美元
預測年份 2032 167.3億美元
複合年成長率 (%) 5.51%

血管支架市場執行摘要

血管支架市場的發展主要受心血管和周邊血管疾病帶來的全球性挑戰所驅動。世界衛生組織（WHO）將心血管疾病列為全球首要死因，每年估計造成1,790萬人死亡。同時，經同行評審的全球疾病負擔研究一致表明，全球整體受周邊動脈疾病影響的人數超過2億。這些臨床現實正在推動對冠狀動脈支架、周邊血管支架、頸動脈支架、覆膜支架、藥物釋放型支架以及新一代生物可吸收和藥物塗層支架的需求。

血管支架產業的變革性變化

血管支架領域正因臨床證據、材料科學和手術技術的創新而不斷重塑。藥物釋放型支架已成為許多冠狀動脈疾病的標準治療方法，近期隨機臨床試驗和指引修訂均證實，與最新的非藥物支架相比，藥物洗脫支架能顯著改善血管再阻塞的發生率。在周邊血管疾病中，基於鎳鈦合金的自動擴張型支架、塗層支架和藥物塗層支架等技術的選擇，則取決於病灶的複雜程度、血管位置、抗破裂性和長期通暢率等數據。

人工智慧對血管支架的累積影響

人工智慧正透過影像分析、手術規劃、生產品管和上市後證據生成等手段，對血管支架生態系統產生日益顯著的影響。人工智慧驅動的影像分割技術能夠從血管造影術、CT 和血管內成像中檢測狹窄、斑塊形態、血管直徑、鈣化和病變長度，從而幫助臨床醫生在支架選擇和植入方面做出更一致的決策。這些應用對於老年糖尿病、慢性腎臟病和多支血管病變等日益複雜的病例尤其重要。

全球血管支架市場的關鍵區域洞察

亞太地區（包括中國、印度、日本、韓國和澳洲）是血管支架的重點市場，因為該地區患者群體龐大，心臟醫療基礎設施不斷完善，糖尿病盛行率持續上升，且經皮冠狀動脈介入治療的普及率不斷提高。日本和韓國擁有成熟的醫療設備核准體系，並在採用先進支架技術方面取得了進展；而中國和印度則需要在提高本地化生產能力、集中採購、價格控制以及擴大介入性心臟病學服務覆蓋範圍之間尋求平衡。

血管支架需求和獲取的關鍵群體分析

隨著新加坡、馬來西亞、泰國、印尼、越南和菲律賓等國心血管醫療服務的擴展，東協市場的重要性日益凸顯。導管檢查室容量的擴大、部分市場的醫療旅遊以及冠狀動脈和周邊動脈疾病診斷數量的增加，都推動了市場需求的成長。採購情況仍然不盡相同：高階支架主要集中在先進的私人醫院，而注重成本控制的公立醫療機構則優先考慮價格、醫生培訓和供應商的可靠性。

深入了解影響血管支架市場的關鍵國家

美國是血管支架的主要市場，這得益於其龐大的心血管治療量、FDA監管下醫療設備的創新、藥物釋放型冠狀動脈支架的廣泛應用，以及血管內成像技術在複雜介入治療中日益普及。加拿大已採用循證採購和公共保險報銷機制，而墨西哥則透過私立醫院和公共心血管計畫提高了血管支架的可及性。巴西是該地區最重要的拉丁美洲市場，這得益於其擁有眾多大型三級醫療中心，以及對冠狀動脈和周邊血管介入治療日益成長的需求。

為血管支架行業的領導者提供的實用建議

產業領導者應優先考慮具有臨床差異化的血管支架平台，這些平台需有可靠的隨機試驗證據、真實世界臨床數據和長期追蹤研究支持。那些展現出低血管再阻塞率、降低血栓症風險、持續通暢性和手術效率的器械將更受臨床醫生、保險公司和醫院價值分析委員會的青睞。相關證據應涵蓋特定的應用場景，例如鈣化病變、小血管、長病變、分叉病變、股膕動脈疾病、頸動脈介入治療、出血高風險患者。

血管支架市場分析的調查方法

本執行摘要基於一套系統性的調查方法，該方法結合了二次調查、監管審查、臨床證據評估和市場三角驗證。所參考的資訊來源包括世界衛生組織 (WHO) 和全球疾病負擔研究提供的公共衛生數據、美國食品藥物管理局(FDA) 和歐洲醫療設備監管機構提供的監管資訊、循環系統學會發布的臨床指南、同行評審的研究、臨床試驗註冊資訊、保險報銷參考資料、公共採購資訊以及醫療設備安全通告。

結論：血管支架市場實證進展

隨著心血管疾病、周邊動脈疾病、糖尿病以及人口老化等因素持續推動對微創血管介入治療的需求，血管支架市場仍佔有重要的策略地位。最大的商機將來自於那些能夠綜合具備以下特性的支架平台：安全性高、通暢通暢性、易於置入、抗破裂性強，並且能夠透過影像引導和人工智慧輔助解決方案與各種治療路徑相容。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 血管支架市場：依產品類型分類

  • 球囊擴張型支架
  • 自動擴張型支架

第8章 血管支架市場：依材料分類

  • 金屬支架
  • 聚合物支架
    • 可生物分解聚合物
    • 不可生物分解聚合物

第9章 血管支架市場：依輸送系統分類

  • 裸金屬支架
  • 覆膜支架
  • 藥物釋放型支架

第10章 血管支架市場：依應用領域分類

  • 缺血性心臟疾病
  • 消化系統疾病
  • 周邊動脈疾病
    • 下肢
    • 上肢

第11章 血管支架市場：依最終用戶分類

  • 門診手術中心
  • 心臟中心
  • 醫院

第12章 血管支架市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 血管支架市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 血管支架市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Artivion Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Biotronik SE & Co. KG
  • Blue Sail Medical Co., Ltd
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group Incorporated
  • Elixir Medical Corporation
  • Endologix LLC
  • iVascular, SLU
  • Kaneka Corporation
  • Kyoto Medical Planning Co., Ltd.
  • Lepu Medical Technology（Beijing）Co.,Ltd.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd
  • Microport Scientific Corporation
  • Otsuka Medical Devices Co., Ltd.
  • Sahajanand Medical Technologies Limited
  • Stryker Corporation
  • Terumo Corporation
  • Translumina GmbH
  • WL Gore & Associates, Inc.
Product Code: MRR-034B5003037F

The Vascular Stent Market is projected to grow by USD 16.73 billion at a CAGR of 5.51% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 11.49 billion
Estimated Year [2026] USD 12.09 billion
Forecast Year [2032] USD 16.73 billion
CAGR (%) 5.51%

Vascular Stent Market Executive Summary

The vascular stent market is anchored by the global burden of cardiovascular and peripheral vascular disease. The World Health Organization identifies cardiovascular disease as the leading cause of death worldwide, responsible for an estimated 17.9 million deaths annually, while peer-reviewed global burden research has consistently placed peripheral artery disease at more than 200 million affected people globally. These clinical realities sustain demand for coronary stents, peripheral vascular stents, carotid stents, covered stents, drug-eluting stents, and next-generation bioresorbable and drug-coated platforms.

Market momentum is supported by the continued shift from open surgical revascularization toward minimally invasive endovascular intervention. Hospitals, ambulatory catheterization laboratories, and specialty cardiovascular centers are prioritizing devices that improve vessel patency, reduce restenosis, shorten hospital stays, and align with value-based care models. At the same time, manufacturers face a more evidence-driven purchasing environment shaped by long-term safety data, health technology assessment, reimbursement scrutiny, and regulatory requirements for post-market surveillance.

Transformative Shifts in the Vascular Stent Landscape

The vascular stent landscape is being reshaped by clinical evidence, material science, and procedural innovation. Drug-eluting stents have become the standard of care for many coronary applications because contemporary randomized trials and guideline updates support improved restenosis outcomes compared with earlier bare-metal stents. In peripheral vascular disease, nitinol self-expanding stents, covered stents, and drug-coated technologies are being selected based on lesion complexity, vessel location, fracture resistance, and long-term patency data.

Another major shift is the convergence of vascular stents with advanced imaging and physiology-guided intervention. Intravascular ultrasound, optical coherence tomography, CT angiography, and fractional flow reserve are improving lesion assessment, stent sizing, deployment accuracy, and follow-up evaluation. These changes are raising the competitive bar: successful manufacturers must demonstrate not only deliverability and radial strength, but also durable clinical outcomes, lower target lesion revascularization, and compatibility with image-guided workflows.

Cumulative Impact of Artificial Intelligence on Vascular Stents

Artificial intelligence is increasingly influencing the vascular stent ecosystem through imaging analytics, procedural planning, manufacturing quality control, and post-market evidence generation. AI-enabled image segmentation can support detection of stenosis, plaque morphology, vessel diameter, calcification, and lesion length from angiography, CT, and intravascular imaging, helping clinicians make more consistent decisions on stent selection and placement. These applications are especially relevant as case complexity rises among aging patients with diabetes, chronic kidney disease, and multivessel disease.

The cumulative impact of AI is also visible outside the catheterization laboratory. Manufacturers are applying machine learning to design optimization, fatigue testing analysis, defect detection, inventory planning, and real-world data monitoring. However, adoption depends on transparent validation, regulatory compliance, cybersecurity, and clinician trust. In a regulated device category where patient safety is paramount, AI will create the most value when it augments physician judgment and is supported by peer-reviewed performance evidence, audited datasets, and explainable outputs.

Key Regional Insights Across Global Vascular Stent Markets

Asia-Pacific is a high-priority region for vascular stents because of large patient populations, expanding cardiac care infrastructure, rising diabetes prevalence, and increasing access to percutaneous coronary intervention in China, India, Japan, South Korea, and Australia. Japan and South Korea have mature device approval systems and strong adoption of advanced stent technologies, while China and India are balancing local manufacturing expansion, centralized procurement, price controls, and broader access to interventional cardiology.

North America remains one of the most clinically advanced vascular stent markets, supported by high procedural volumes, established reimbursement pathways, strong adoption of drug-eluting stents, and extensive real-world evidence generation. Europe combines sophisticated cardiovascular care with the Medical Device Regulation framework, which has increased expectations for clinical evidence, post-market surveillance, and notified body review. Latin America shows rising demand in Brazil and Mexico as private hospital networks and public cardiovascular programs expand, although reimbursement variability affects premium device uptake.

The Middle East is investing in specialty hospitals and cardiovascular centers, particularly across Gulf health systems, where chronic disease management is a policy priority. Africa remains more uneven, with demand concentrated in urban tertiary hospitals and constrained by specialist availability, affordability, and catheterization laboratory infrastructure. Across all regions, the strongest opportunities are tied to evidence-backed stent platforms that improve long-term patency, support complex lesions, and fit local reimbursement realities.

Key Group Insights for Vascular Stent Demand and Access

ASEAN markets are gaining importance as cardiovascular care expands in Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines. Demand is supported by increasing catheterization laboratory capacity, medical tourism in selected markets, and rising diagnosis of coronary and peripheral artery disease. Procurement remains mixed, with premium stents concentrated in advanced private hospitals and cost-sensitive public systems emphasizing affordability, physician training, and supplier reliability.

The GCC is characterized by high investment in hospital infrastructure and a significant burden of diabetes, obesity, and cardiovascular risk factors, supporting demand for coronary and peripheral stenting. The European Union is shaped by harmonized regulatory expectations under the EU Medical Device Regulation, making clinical evidence, traceability, and post-market performance central to market access. BRICS countries represent a large-volume opportunity, led by China, India, and Brazil, but require localization strategies, pricing discipline, and navigation of public procurement systems.

G7 markets remain innovation leaders because they combine advanced cardiology practice, strong reimbursement structures, clinical trial networks, and sophisticated regulatory oversight. NATO countries overlap substantially with high-income North American and European markets, where supply chain security, device quality, and trusted sourcing are increasingly relevant to hospital procurement. Across these groups, success depends on aligning clinical differentiation with affordability, regulatory compliance, and health-system priorities.

Key Country Insights Shaping the Vascular Stent Market

The United States is a leading market for vascular stents due to large cardiovascular procedure volumes, FDA-regulated device innovation, broad use of drug-eluting coronary stents, and growing adoption of intravascular imaging in complex interventions. Canada follows evidence-based procurement and public reimbursement pathways, while Mexico is expanding access through private hospitals and public cardiovascular programs. Brazil is the most significant Latin American market in this country set, supported by major tertiary centers and a growing need for coronary and peripheral interventions.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain advanced interventional cardiology capabilities and high adoption of guideline-supported stent technologies. Germany is particularly important because of its hospital density, engineering ecosystem, and role in European medical device adoption. France, Italy, and Spain combine strong public health systems with cost-effectiveness scrutiny, while the United Kingdom emphasizes National Health Service procurement efficiency and outcomes-based care. Russia has procedural demand but faces market access complexities related to procurement, localization, and geopolitical constraints.

China and India are central to global procedure growth. China benefits from expanding domestic manufacturing, centralized procurement reforms, and a large patient base, while India has growing catheterization capacity and a highly price-sensitive market shaped by stent price regulation. Japan remains a premium, technologically advanced market with rigorous clinical expectations, Australia has a stable reimbursement environment and advanced cardiovascular centers, and South Korea combines rapid technology adoption with strong domestic healthcare infrastructure.

Actionable Recommendations for Vascular Stent Industry Leaders

Industry leaders should prioritize clinically differentiated vascular stent platforms supported by robust randomized evidence, real-world data, and long-term follow-up. Devices that demonstrate lower restenosis, reduced thrombosis risk, durable patency, and procedural efficiency will be better positioned with clinicians, payers, and hospital value analysis committees. Evidence packages should address specific use cases, including calcified lesions, small vessels, long lesions, bifurcations, femoropopliteal disease, carotid intervention, and high-bleeding-risk patients.

Manufacturers should strengthen regional market access strategies by aligning product portfolios with local reimbursement, procurement, and affordability conditions. In mature markets, the focus should be on premium innovation, image-guided compatibility, and outcomes evidence. In emerging markets, competitive pricing, physician training, reliable distribution, and local partnerships are essential. Leaders should also invest in AI-enabled workflow tools, post-market surveillance systems, regulatory documentation, and manufacturing resilience to protect quality, compliance, and supply continuity.

Research Methodology for Vascular Stent Market Analysis

This executive summary is based on a structured research methodology combining secondary research, regulatory review, clinical evidence assessment, and market triangulation. Sources considered include public health data from the World Health Organization and Global Burden of Disease research, regulatory information from agencies such as the U.S. Food and Drug Administration and European medical device authorities, clinical guidance from cardiovascular societies, peer-reviewed studies, clinical trial registries, reimbursement references, public procurement information, and device safety communications.

The analysis emphasizes verified, data-backed indicators rather than speculative assumptions. Key variables include disease burden, procedure trends, stent technology adoption, regulatory requirements, reimbursement conditions, hospital purchasing behavior, regional healthcare infrastructure, and competitive innovation. Insights were triangulated across clinical, commercial, and policy evidence to support an optimized but evidence-led perspective on the vascular stent market.

Conclusion: Evidence-Led Progress in the Vascular Stent Market

The vascular stent market remains strategically important as cardiovascular disease, peripheral artery disease, diabetes, and population aging continue to drive demand for minimally invasive vascular intervention. The strongest opportunities will come from stent platforms that combine proven safety, durable patency, deliverability, fracture resistance, and compatibility with image-guided and AI-supported care pathways.

Competitive advantage will depend on evidence depth, regulatory readiness, regional adaptability, and the ability to support clinicians across increasingly complex cases. Organizations that align innovation with affordability, real-world outcomes, and health-system priorities will be best positioned for sustainable relevance in the global vascular stent industry.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Vascular Stent Market, by Product Type

  • 7.1. Balloon-Expandable Stents
  • 7.2. Self-Expanding Stents

8. Vascular Stent Market, by Material

  • 8.1. Metallic Stents
  • 8.2. Polymeric Stents
    • 8.2.1. Biodegradable Polymers
    • 8.2.2. Non-Biodegradable Polymers

9. Vascular Stent Market, by Delivery System

  • 9.1. Bare Metal Stents
  • 9.2. Covered Stents
  • 9.3. Drug Eluting Stents

10. Vascular Stent Market, by Application

  • 10.1. Coronary Artery Disease
  • 10.2. Gastrointestinal Disease
  • 10.3. Peripheral Artery Disease
    • 10.3.1. Lower Extremities
    • 10.3.2. Upper Extremities

11. Vascular Stent Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Cardiac Centers
  • 11.3. Hospitals

12. Vascular Stent Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Vascular Stent Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Vascular Stent Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Artivion Inc.
  • 16.3. B. Braun SE
  • 16.4. Becton, Dickinson and Company
  • 16.5. Biotronik SE & Co. KG
  • 16.6. Blue Sail Medical Co., Ltd
  • 16.7. Boston Scientific Corporation
  • 16.8. Cardinal Health, Inc.
  • 16.9. Cook Group Incorporated
  • 16.10. Elixir Medical Corporation
  • 16.11. Endologix LLC
  • 16.12. iVascular, S.L.U
  • 16.13. Kaneka Corporation
  • 16.14. Kyoto Medical Planning Co., Ltd.
  • 16.15. Lepu Medical Technology(Beijing)Co.,Ltd.
  • 16.16. Medtronic PLC
  • 16.17. Meril Life Sciences Pvt. Ltd
  • 16.18. Microport Scientific Corporation
  • 16.19. Otsuka Medical Devices Co., Ltd.
  • 16.20. Sahajanand Medical Technologies Limited
  • 16.21. Stryker Corporation
  • 16.22. Terumo Corporation
  • 16.23. Translumina GmbH
  • 16.24. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VASCULAR STENT MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VASCULAR STENT MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VASCULAR STENT MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VASCULAR STENT MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VASCULAR STENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL VASCULAR STENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VASCULAR STENT MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VASCULAR STENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VASCULAR STENT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VASCULAR STENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VASCULAR STENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VASCULAR STENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VASCULAR STENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL VASCULAR STENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BALLOON-EXPANDABLE STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BALLOON-EXPANDABLE STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BALLOON-EXPANDABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SELF-EXPANDING STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SELF-EXPANDING STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SELF-EXPANDING STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL METALLIC STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL METALLIC STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL METALLIC STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL POLYMERIC STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL POLYMERIC STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL POLYMERIC STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIODEGRADABLE POLYMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIODEGRADABLE POLYMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIODEGRADABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NON-BIODEGRADABLE POLYMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NON-BIODEGRADABLE POLYMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NON-BIODEGRADABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BARE METAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BARE METAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BARE METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL COVERED STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL COVERED STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL COVERED STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DRUG ELUTING STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DRUG ELUTING STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DRUG ELUTING STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTROINTESTINAL DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROINTESTINAL DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTROINTESTINAL DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL ARTERY DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL ARTERY DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LOWER EXTREMITIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LOWER EXTREMITIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LOWER EXTREMITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL UPPER EXTREMITIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL UPPER EXTREMITIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL UPPER EXTREMITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CARDIAC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CARDIAC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CARDIAC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VASCULAR STENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL VASCULAR STENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. GCC VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 117. GCC VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. GCC VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 119. GCC VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 120. GCC VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 121. GCC VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. GCC VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 123. GCC VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. G7 VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 141. G7 VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. G7 VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 143. G7 VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 144. G7 VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 145. G7 VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. G7 VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 147. G7 VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. NATO VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. NATO VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. NATO VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. NATO VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 152. NATO VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 153. NATO VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. NATO VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 155. NATO VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. CANADA VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 166. CANADA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. CANADA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 168. CANADA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 169. CANADA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 170. CANADA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. CANADA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 172. CANADA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. MEXICO VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. MEXICO VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. MEXICO VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 176. MEXICO VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 177. MEXICO VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 178. MEXICO VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. MEXICO VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 180. MEXICO VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. BRAZIL VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. BRAZIL VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. BRAZIL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 184. BRAZIL VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 185. BRAZIL VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 186. BRAZIL VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. BRAZIL VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 188. BRAZIL VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED KINGDOM VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. GERMANY VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 198. GERMANY VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. GERMANY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 200. GERMANY VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 201. GERMANY VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 202. GERMANY VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. GERMANY VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 204. GERMANY VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. FRANCE VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. FRANCE VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. FRANCE VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 208. FRANCE VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 209. FRANCE VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 210. FRANCE VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. FRANCE VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 212. FRANCE VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. RUSSIA VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 214. RUSSIA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. RUSSIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 216. RUSSIA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 217. RUSSIA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 218. RUSSIA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. RUSSIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 220. RUSSIA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. ITALY VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 222. ITALY VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. ITALY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. ITALY VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 225. ITALY VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 226. ITALY VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. ITALY VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 228. ITALY VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. SPAIN VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. SPAIN VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. SPAIN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 232. SPAIN VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 233. SPAIN VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 234. SPAIN VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. SPAIN VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 236. SPAIN VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. INDIA VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. INDIA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. INDIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 248. INDIA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 249. INDIA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 250. INDIA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. INDIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 252. INDIA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. JAPAN VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. JAPAN VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. JAPAN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 256. JAPAN VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 257. JAPAN VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 258. JAPAN VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. JAPAN VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 260. JAPAN VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. AUSTRALIA VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. AUSTRALIA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. AUSTRALIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 264. AUSTRALIA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 265. AUSTRALIA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 266. AUSTRALIA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 267. AUSTRALIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 268. AUSTRALIA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. SOUTH KOREA VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 272. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 273. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 274. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2032 (USD MILLION)
  • TABLE 276. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)